Share Price and Basic Stock Data
Last Updated: December 13, 2025, 7:29 am
| PEG Ratio | 0.79 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balmer Lawrie & Company Ltd operates within a diversified industry, showcasing a rich tapestry of services ranging from logistics to manufacturing. The company has seen a gradual recovery in its revenue streams, with sales reported at ₹2,312 Cr for FY 2023, a modest increase from ₹2,051 Cr in FY 2022. This upward trajectory is noteworthy, particularly when considering the challenges posed by economic fluctuations and the pandemic’s lingering effects. The trailing twelve-month (TTM) revenue stands at ₹2,558 Cr, indicating a robust performance in the recent quarters. For instance, sales in the June 2023 quarter were ₹592 Cr, slightly down from ₹608 Cr in March 2023, but still reflective of a solid operational base. The consistent sales figures hint at resilience and adaptability, vital traits for navigating market volatility. However, the company’s journey hasn’t been devoid of hurdles, as evidenced by the dip in quarterly sales during the latter part of 2022, where it fell to ₹514 Cr in December 2022.
Profitability and Efficiency Metrics
On the profitability front, Balmer Lawrie has demonstrated commendable efficiency, with an operating profit margin (OPM) of 12% for FY 2025. This figure, while slightly down from 13% in FY 2024, still reflects the company’s ability to manage costs effectively amidst fluctuating sales. The net profit for FY 2025 rose to ₹259 Cr, showcasing an upward trend from ₹168 Cr in FY 2023. Notably, the company’s return on equity (ROE) stands at a respectable 14%, further emphasizing its ability to generate returns for shareholders. Efficiency ratios, like the cash conversion cycle of 33 days, indicate a streamlined operation, allowing the company to convert its investments into cash quickly. However, the consistency in OPM could be a concern, as fluctuations in operating expenses may pressure margins. Overall, while Balmer Lawrie’s profitability metrics appear strong, continuous monitoring of cost management will be crucial to maintain this performance.
Balance Sheet Strength and Financial Ratios
Turning to the balance sheet, Balmer Lawrie showcases a solid foundation with total assets reported at ₹3,040 Cr and a minimal debt level of ₹237 Cr. This equates to a debt-to-equity ratio of just 0.03, indicating a very low reliance on borrowed funds, which is a significant strength in today’s economic environment. The company also boasts reserves of ₹1,773 Cr, providing a buffer against any unforeseen market downturns. Furthermore, the interest coverage ratio of 13.67x stands out, allowing it to comfortably meet interest obligations. The price-to-book value ratio of 1.60x suggests that the stock is reasonably valued compared to its net assets. However, the increase in borrowings from ₹106 Cr in FY 2025 to ₹237 Cr in September 2025 raises questions about future capital requirements and financial flexibility. Investors should keep an eye on how this debt is utilized to ensure it contributes to growth rather than becoming a burden.
Shareholding Pattern and Investor Confidence
The shareholding structure of Balmer Lawrie reveals a broad base of public investors, holding 95.94% of the shares, which speaks to robust retail interest. This is complemented by foreign institutional investors (FIIs) holding 2.26% and domestic institutional investors (DIIs) at 1.79%. The stability of this shareholder base is crucial, as it reflects investor confidence in the company’s long-term prospects. Over the past few quarters, FII participation has shown a gradual increase, rising from 1.20% in March 2023 to 2.26% by September 2025. This uptick suggests that institutional investors are starting to take note of Balmer Lawrie’s performance and potential, a positive sign for retail investors. However, the absence of significant promoter holdings could raise questions about long-term strategic alignment and governance. Investors may want to consider the implications of this structure as they evaluate the company’s future growth trajectory.
Outlook, Risks, and Final Insight
As we look ahead, Balmer Lawrie presents a mixed bag of opportunities and risks. The company’s strong revenue growth, coupled with healthy profitability metrics, positions it well within its industry. However, the potential volatility in operating margins, coupled with rising debt levels, poses a risk that investors should not overlook. The shift in shareholder dynamics, particularly with increased institutional interest, could bolster investor confidence but also highlights the need for strong governance to manage such a diverse base. Moreover, external factors like economic fluctuations and regulatory changes could impact performance. In summary, while Balmer Lawrie appears well-positioned for growth, investors should remain vigilant about the evolving landscape and how the company navigates its challenges. A balanced assessment of its strengths and potential vulnerabilities will be key in determining its attractiveness as an investment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,763 Cr. | 1,244 | 1,639/842 | 21.2 | 397 | 0.52 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 19,412 Cr. | 1,245 | 1,502/903 | 27.2 | 463 | 0.72 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,041 Cr. | 178 | 238/147 | 11.5 | 114 | 4.78 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 39,969 Cr. | 35,465 | 37,000/25,714 | 65.4 | 1,906 | 0.45 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 17,796.25 Cr | 9,533.00 | 31.33 | 720.00 | 1.62% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 648 | 551 | 514 | 608 | 592 | 586 | 585 | 577 | 638 | 639 | 630 | 608 | 681 |
| Expenses | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 546 | 514 | 597 |
| Operating Profit | 61 | 39 | 50 | 52 | 65 | 75 | 74 | 91 | 64 | 70 | 84 | 95 | 83 |
| OPM % | 9% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 13% | 16% | 12% |
| Other Income | 8 | 8 | 3 | 17 | 10 | 13 | 11 | 18 | 12 | 11 | 9 | 18 | 9 |
| Interest | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 |
| Profit before tax | 51 | 29 | 34 | 51 | 54 | 69 | 64 | 88 | 56 | 62 | 68 | 90 | 71 |
| Tax % | 22% | 37% | 29% | 51% | 22% | 31% | 24% | 31% | 20% | 30% | 29% | 35% | 27% |
| Net Profit | 55 | 34 | 35 | 43 | 56 | 63 | 66 | 73 | 63 | 61 | 62 | 74 | 67 |
| EPS in Rs | 3.28 | 2.05 | 2.11 | 2.61 | 3.35 | 3.73 | 3.90 | 4.31 | 3.73 | 3.66 | 3.77 | 4.39 | 4.03 |
Last Updated: August 20, 2025, 1:10 pm
Below is a detailed analysis of the quarterly data for Balmer Lawrie & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 681.00 Cr.. The value appears strong and on an upward trend. It has increased from 608.00 Cr. (Mar 2025) to 681.00 Cr., marking an increase of 73.00 Cr..
- For Expenses, as of Jun 2025, the value is 597.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 597.00 Cr., marking an increase of 83.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 12.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 71.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 71.00 Cr., marking a decrease of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to 27.00%, marking a decrease of 8.00%.
- For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.03. The value appears to be declining and may need further review. It has decreased from 4.39 (Mar 2025) to 4.03, marking a decrease of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,120 | 3,254 | 1,591 | 1,702 | 1,720 | 1,772 | 1,532 | 1,526 | 2,051 | 2,312 | 2,328 | 2,505 | 2,558 |
| Expenses | 2,908 | 3,031 | 1,386 | 1,492 | 1,502 | 1,539 | 1,342 | 1,385 | 1,882 | 2,109 | 2,023 | 2,192 | 2,226 |
| Operating Profit | 212 | 223 | 205 | 211 | 219 | 233 | 189 | 141 | 169 | 202 | 305 | 313 | 332 |
| OPM % | 7% | 7% | 13% | 12% | 13% | 13% | 12% | 9% | 8% | 9% | 13% | 12% | 13% |
| Other Income | 70 | 64 | 63 | 56 | 51 | 51 | 51 | 49 | 37 | 37 | 51 | 50 | 47 |
| Interest | 24 | 23 | 5 | 5 | 4 | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 27 |
| Depreciation | 35 | 46 | 24 | 26 | 27 | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 60 |
| Profit before tax | 222 | 218 | 240 | 236 | 238 | 247 | 173 | 123 | 136 | 164 | 274 | 276 | 292 |
| Tax % | 30% | 30% | 32% | 34% | 31% | 35% | 32% | 33% | 35% | 35% | 27% | 29% | |
| Net Profit | 156 | 152 | 164 | 155 | 165 | 197 | 155 | 115 | 134 | 168 | 236 | 259 | 264 |
| EPS in Rs | 9.09 | 8.89 | 9.58 | 9.05 | 9.66 | 11.65 | 9.43 | 7.04 | 8.05 | 10.05 | 14.02 | 15.55 | 15.85 |
| Dividend Payout % | 27% | 34% | 35% | 52% | 69% | 63% | 80% | 85% | 81% | 75% | 61% | 55% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.56% | 7.89% | -5.49% | 6.45% | 19.39% | -21.32% | -25.81% | 16.52% | 25.37% | 40.48% | 9.75% |
| Change in YoY Net Profit Growth (%) | 0.00% | 10.46% | -13.38% | 11.94% | 12.94% | -40.71% | -4.49% | 42.33% | 8.85% | 15.10% | -30.73% |
Balmer Lawrie & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 25% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 114 | 114 | 114 | 171 | 171 | 171 | 171 | 171 | 171 | 171 |
| Reserves | 953 | 1,015 | 1,210 | 1,247 | 1,342 | 1,406 | 1,383 | 1,371 | 1,416 | 1,510 | 1,650 | 1,798 | 1,773 |
| Borrowings | 175 | 197 | 0 | 0 | 15 | 81 | 120 | 125 | 122 | 121 | 113 | 106 | 237 |
| Other Liabilities | 724 | 670 | 559 | 669 | 720 | 682 | 660 | 712 | 736 | 860 | 939 | 966 | 1,049 |
| Total Liabilities | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
| Fixed Assets | 464 | 577 | 393 | 397 | 410 | 568 | 770 | 767 | 767 | 760 | 751 | 737 | 789 |
| CWIP | 77 | 12 | 11 | 63 | 138 | 117 | 24 | 32 | 11 | 28 | 52 | 67 | 79 |
| Investments | 0 | 0 | 248 | 271 | 293 | 325 | 375 | 386 | 436 | 518 | 565 | 632 | 669 |
| Other Assets | 1,339 | 1,322 | 1,146 | 1,299 | 1,350 | 1,272 | 1,165 | 1,194 | 1,231 | 1,356 | 1,505 | 1,604 | 1,693 |
| Total Assets | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 171.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 171.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,798.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 237.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 106.00 Cr. (Mar 2025) to 237.00 Cr., marking an increase of 131.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,049.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 966.00 Cr. (Mar 2025) to 1,049.00 Cr., marking an increase of 83.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 789.00 Cr.. The value appears strong and on an upward trend. It has increased from 737.00 Cr. (Mar 2025) to 789.00 Cr., marking an increase of 52.00 Cr..
- For CWIP, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 669.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2025) to 669.00 Cr., marking an increase of 37.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,693.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,604.00 Cr. (Mar 2025) to 1,693.00 Cr., marking an increase of 89.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
Notably, the Reserves (1,773.00 Cr.) exceed the Borrowings (237.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 37.00 | 26.00 | 205.00 | 211.00 | 204.00 | 152.00 | 69.00 | 16.00 | 47.00 | 81.00 | 192.00 | 207.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 53 | 53 | 60 | 57 | 57 | 65 | 69 | 56 | 57 | 67 | 70 |
| Inventory Days | 48 | 48 | 77 | 51 | 46 | 47 | 57 | 59 | 51 | 46 | 66 | 67 |
| Days Payable | 53 | 44 | 144 | 104 | 108 | 96 | 88 | 100 | 69 | 68 | 108 | 104 |
| Cash Conversion Cycle | 57 | 56 | -14 | 8 | -4 | 8 | 35 | 28 | 38 | 35 | 25 | 33 |
| Working Capital Days | 23 | 23 | -24 | 30 | 39 | 44 | 49 | 30 | 49 | 39 | 39 | 62 |
| ROCE % | 22% | 20% | 20% | 18% | 17% | 16% | 11% | 8% | 8% | 10% | 16% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 92,092 | 0.26 | 2.25 | 92,092 | 2025-04-22 17:25:41 | 0% |
| Groww Nifty Total Market Index Fund | 394 | 0.01 | 0.01 | 394 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Diluted EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Cash EPS (Rs.) | 14.92 | 15.11 | 9.57 | 8.49 | 8.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Revenue From Operations / Share (Rs.) | 147.11 | 136.79 | 135.76 | 120.19 | 89.41 |
| PBDIT / Share (Rs.) | 21.20 | 20.80 | 13.98 | 12.06 | 11.09 |
| PBIT / Share (Rs.) | 17.68 | 17.34 | 10.66 | 8.79 | 7.88 |
| PBT / Share (Rs.) | 16.13 | 16.05 | 9.61 | 8.00 | 7.18 |
| Net Profit / Share (Rs.) | 11.39 | 11.65 | 6.25 | 5.23 | 4.83 |
| NP After MI And SOA / Share (Rs.) | 15.55 | 15.30 | 10.05 | 7.88 | 6.74 |
| PBDIT Margin (%) | 14.41 | 15.20 | 10.29 | 10.03 | 12.40 |
| PBIT Margin (%) | 12.01 | 12.67 | 7.85 | 7.31 | 8.80 |
| PBT Margin (%) | 10.96 | 11.73 | 7.07 | 6.65 | 8.03 |
| Net Profit Margin (%) | 7.74 | 8.52 | 4.60 | 4.35 | 5.40 |
| NP After MI And SOA Margin (%) | 10.57 | 11.18 | 7.40 | 6.55 | 7.54 |
| Return on Networth / Equity (%) | 13.50 | 14.36 | 10.22 | 8.48 | 7.47 |
| Return on Capital Employeed (%) | 12.90 | 13.71 | 9.02 | 7.83 | 7.27 |
| Return On Assets (%) | 8.74 | 9.10 | 6.45 | 5.50 | 4.84 |
| Long Term Debt / Equity (X) | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 |
| Total Debt / Equity (X) | 0.03 | 0.04 | 0.05 | 0.05 | 0.06 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.90 | 0.94 | 0.71 |
| Current Ratio (X) | 2.27 | 2.08 | 2.09 | 2.31 | 2.24 |
| Quick Ratio (X) | 1.99 | 1.81 | 1.77 | 1.93 | 1.94 |
| Inventory Turnover Ratio (X) | 13.04 | 5.07 | 7.88 | 5.34 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 54.65 | 49.03 | 64.67 | 76.14 | 111.23 |
| Dividend Payout Ratio (CP) (%) | 44.55 | 39.98 | 48.61 | 53.84 | 75.30 |
| Earning Retention Ratio (%) | 45.35 | 50.97 | 35.33 | 23.86 | -11.23 |
| Cash Earning Retention Ratio (%) | 55.45 | 60.02 | 51.39 | 46.16 | 24.70 |
| Interest Coverage Ratio (X) | 13.67 | 16.13 | 13.33 | 15.17 | 15.92 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 10.04 | 6.96 | 7.58 | 7.93 |
| Enterprise Value (Cr.) | 2796.58 | 3661.98 | 1567.62 | 1642.42 | 1805.18 |
| EV / Net Operating Revenue (X) | 1.11 | 1.57 | 0.67 | 0.79 | 1.18 |
| EV / EBITDA (X) | 7.71 | 10.30 | 6.56 | 7.97 | 9.51 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| Retention Ratios (%) | 45.34 | 50.96 | 35.32 | 23.85 | -11.23 |
| Price / BV (X) | 1.60 | 2.24 | 1.13 | 1.21 | 1.43 |
| Price / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| EarningsYield | 0.08 | 0.06 | 0.09 | 0.06 | 0.05 |
After reviewing the key financial ratios for Balmer Lawrie & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.92. This value is within the healthy range. It has decreased from 15.11 (Mar 24) to 14.92, marking a decrease of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 147.11. It has increased from 136.79 (Mar 24) to 147.11, marking an increase of 10.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.20. This value is within the healthy range. It has increased from 20.80 (Mar 24) to 21.20, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 17.34 (Mar 24) to 17.68, marking an increase of 0.34.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.13. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 16.13, marking an increase of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 11.65 (Mar 24) to 11.39, marking a decrease of 0.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For PBDIT Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.20 (Mar 24) to 14.41, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 12.01, marking a decrease of 0.66.
- For PBT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 10.96, marking a decrease of 0.77.
- For Net Profit Margin (%), as of Mar 25, the value is 7.74. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.74, marking a decrease of 0.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.57, marking a decrease of 0.61.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.50. This value is below the healthy minimum of 15. It has decreased from 14.36 (Mar 24) to 13.50, marking a decrease of 0.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has decreased from 13.71 (Mar 24) to 12.90, marking a decrease of 0.81.
- For Return On Assets (%), as of Mar 25, the value is 8.74. This value is within the healthy range. It has decreased from 9.10 (Mar 24) to 8.74, marking a decrease of 0.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has increased from 0.84 (Mar 24) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 2.08 (Mar 24) to 2.27, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 1.99, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.04. This value exceeds the healthy maximum of 8. It has increased from 5.07 (Mar 24) to 13.04, marking an increase of 7.97.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.65. This value exceeds the healthy maximum of 50. It has increased from 49.03 (Mar 24) to 54.65, marking an increase of 5.62.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 44.55. This value is within the healthy range. It has increased from 39.98 (Mar 24) to 44.55, marking an increase of 4.57.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.35. This value is within the healthy range. It has decreased from 50.97 (Mar 24) to 45.35, marking a decrease of 5.62.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 55.45. This value is within the healthy range. It has decreased from 60.02 (Mar 24) to 55.45, marking a decrease of 4.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 16.13 (Mar 24) to 13.67, marking a decrease of 2.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has decreased from 10.04 (Mar 24) to 8.34, marking a decrease of 1.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,796.58. It has decreased from 3,661.98 (Mar 24) to 2,796.58, marking a decrease of 865.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.11, marking a decrease of 0.46.
- For EV / EBITDA (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 7.71, marking a decrease of 2.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 45.34. This value is within the healthy range. It has decreased from 50.96 (Mar 24) to 45.34, marking a decrease of 5.62.
- For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.60, marking a decrease of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.08, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie & Company Ltd:
- Net Profit Margin: 7.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.9% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.5% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.5 (Industry average Stock P/E: 31.33)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | bhavsar.k@balmerlawrie.com http://www.balmerlawrie.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Adhip Nath Palchaudhuri | Chairman & Managing Director |
| Mr. Saurav Dutta | Director - Finance & CFO |
| Dr. Vandana Minda Heda | Independent Director |
| Mr. Rajeev Kumar | Government Nominee Director |
| Mr. Raja Mani Uthayaraja | Director - Manufacturing Businesses |
| Mr. Abhijit Ghosh | Director - HR & Corporate Affairs |
| Mr. Romon Sebastian Louis | Director - Service Businesses |
| Mr. Harishkumar Madhusudan Joshi | Independent Director |
FAQ
What is the intrinsic value of Balmer Lawrie & Company Ltd?
Balmer Lawrie & Company Ltd's intrinsic value (as of 13 December 2025) is 153.85 which is 13.57% lower the current market price of 178.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,041 Cr. market cap, FY2025-2026 high/low of 238/147, reserves of ₹1,773 Cr, and liabilities of 3,230 Cr.
What is the Market Cap of Balmer Lawrie & Company Ltd?
The Market Cap of Balmer Lawrie & Company Ltd is 3,041 Cr..
What is the current Stock Price of Balmer Lawrie & Company Ltd as on 13 December 2025?
The current stock price of Balmer Lawrie & Company Ltd as on 13 December 2025 is 178.
What is the High / Low of Balmer Lawrie & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie & Company Ltd stocks is 238/147.
What is the Stock P/E of Balmer Lawrie & Company Ltd?
The Stock P/E of Balmer Lawrie & Company Ltd is 11.5.
What is the Book Value of Balmer Lawrie & Company Ltd?
The Book Value of Balmer Lawrie & Company Ltd is 114.
What is the Dividend Yield of Balmer Lawrie & Company Ltd?
The Dividend Yield of Balmer Lawrie & Company Ltd is 4.78 %.
What is the ROCE of Balmer Lawrie & Company Ltd?
The ROCE of Balmer Lawrie & Company Ltd is 14.8 %.
What is the ROE of Balmer Lawrie & Company Ltd?
The ROE of Balmer Lawrie & Company Ltd is 14.0 %.
What is the Face Value of Balmer Lawrie & Company Ltd?
The Face Value of Balmer Lawrie & Company Ltd is 10.0.